[NBIX] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
29-Apr-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -664.86%
YoY- -144.19%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 310,600 236,600 237,100 138,403 71,086 0 15,000 65.67%
PBT 21,400 27,200 38,900 -102,594 -41,818 -78,326 -19,264 -
Tax 7,500 -4,900 1,500 -479 7,504 -1,606 -1,593 -
NP 13,900 32,100 37,400 -102,115 -41,818 -78,326 -19,264 -
Tax Rate -35.05% 18.01% -3.86% - - - - -
Total Cost 296,700 204,500 199,700 240,518 112,904 78,326 34,264 43.27%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 4.48 13.57 15.77 -73.78 -58.83 0.00 -128.43 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS 0.15 0.34 0.40 -1.12 -0.47 -0.90 -0.22 -
EPS Diluted 0.14 0.33 0.39 -1.12 -0.47 -0.90 -0.22 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.